Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.24 USD | -5.01% | -4.78% | -28.14% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 50.01 | 56.36 | 58.11 |
Spread/Res. | -13.54% | -23.28% | -25.59% |
Spread/Supp. | +10.79% | +20.55% | +17.25% |
Support | 39.03 | 35.87 | 36.88 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- LEGN Stock
- Charts Legend Biotech Corporation